- Safe Re-administration of Tumor Necrosis Factor-alpha (TNFalpha) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFalpha Therapy
-
Suh YS, Kwok SK, Ju JH, Park KS, Park SH, Yoon CH
- KMID: 1796912
- J Korean Med Sci.
- 2014 Jan;29(1):38-42.
- doi: 10.3346/jkms.2014.29.1.38
There is no consensus on whether it is safe to re-administer tumor necrosis factor-alpha (TNFalpha) inhibitors in patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) flared after withdrawal of... -
- CITED
-
- Close
- SHARE
-
- Close
- The specialist physician's approach to rheumatoid arthritis in South Africa
-
Bester FC, Bosch FJ, van Rensburg BJJ
- KMID: 2373797
- Korean J Intern Med.
- 2016 Mar;31(2):219-236.
- doi: 10.3904/kjim.2015.134
Rheumatoid arthritis (RA) is expected to increase in Africa and South Africa. Due to the low numbers of rheumatologists in South Africa, specialist physicians also have to care for patients... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency
-
Park GT, Jeon DW, Roh KH, Mun HS, Lee CH, Park CH, Kang KW, Kim SM, Kang JM, Park HC
- KMID: 759089
- Korean J Intern Med.
- 1999 Jan;14(1):85-87.
Most reports on serious MTX toxicity have focused on hepatic abnormalities, while other effects, including hematologic reactions, have not been emphasized. We experienced a case of pancytopenia secondary... -
- CITED
-
- Close
- SHARE
-
- Close
- Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
-
Son CN, Jun JB, Kim JH, Sung IH, Yoo DH, Kim TH
- KMID: 2129603
- J Korean Med Sci.
- 2014 Aug;29(8):1090-1093.
- doi: 10.3346/jkms.2014.29.8.1090
We evaluated the utility of follow-up interferon-gamma release assays (IGRAs) for the diagnosis of reactivation of latent tuberculosis infection (LTBI) or new tuberculosis in ankylosing spondylitis (AS) patients receiving anti-tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
-
Koo BS, Hong S, Kim YJ, Kim YG, Lee CK, Yoo B
- KMID: 2129670
- Korean J Intern Med.
- 2015 Jan;30(1):104-109.
- doi: 10.3904/kjim.2015.30.1.104
BACKGROUND/AIMS: To evaluate the impact on mortality of anti-tumor necrosis factor (anti-TNF) treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). METHODS: We retrospectively reviewed the medical records of 100 RA-ILD patients... -
- CITED
-
- Close
- SHARE
-
- Close
